Latest Articles

30. 09. 2019

List of reimbursed medicinal products valid as of 1.10.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

30. 08. 2019

List of reimbursed medicinal products valid as of 1.9.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

26. 08. 2019

Procedure for the Submission of Applications for Mutual Recognition of Marketing Authorisations with the Czech Republic Acting as the RMS

SÚKL hereby specifies the requirements governing the submission of applications for marketing authorisation mutual recognition procedures with the Czech Republic acting as...

 

31. 07. 2019

List of reimbursed medicinal products valid as of 1.8.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

28. 06. 2019

List of reimbursed medicinal products valid as of 1.7.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

08. 06. 2019

Correction of the List of reimbursed medicinal products valid as of 8.6.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

31. 05. 2019

List of reimbursed medicinal products valid as of 1.6.2019

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

02. 05. 2019

Safety Features on the Packaging of Authorised Medicinal Products vs. Clinical Trials on Pharmaceuticals

In what form is it necessary to place safety features on the packaging of a medicinal product used within the scope of a clinical trial?